FR12C0077I2 - Composition for the treatment of genital warts - Google Patents

Composition for the treatment of genital warts

Info

Publication number: FR12C0077I2
Authority: FR; France
Prior art keywords: treatment; composition; genital warts; warts; genital
Prior art date: 1996-11-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR12C0077C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Cancer Inst Chinese Academy Medical Sciences

Mitsui Norin Co Ltd

Original Assignee

Cancer Inst Chinese Academy Medical Sciences

Mitsui Norin Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-18

Filing date

2012-12-20

Publication date

2013-08-16

2012-12-20 Application filed by Cancer Inst Chinese Academy Medical Sciences, Mitsui Norin Co Ltd filed Critical Cancer Inst Chinese Academy Medical Sciences

2013-02-01 Publication of FR12C0077I1 publication Critical patent/FR12C0077I1/fr

2013-08-16 Application granted granted Critical

2013-08-16 Publication of FR12C0077I2 publication Critical patent/FR12C0077I2/en

Status Active legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Dermatology (AREA)
Biotechnology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Medicinal Preparation (AREA)
Pyrane Compounds (AREA)
Epoxy Compounds (AREA)

FR12C0077C 1996-11-18 2012-12-20 Composition for the treatment of genital warts Active FR12C0077I2 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP32119596A JP3213557B2 (en)	1996-11-18	1996-11-18	A remedy for condyloma acuminatum containing tea catechin as an active ingredient

Publications (2)

Publication Number	Publication Date
FR12C0077I1 FR12C0077I1 (en)	2013-02-01
FR12C0077I2 true FR12C0077I2 (en)	2013-08-16

Family

ID=18129859

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR12C0077C Active FR12C0077I2 (en)	1996-11-18	2012-12-20	Composition for the treatment of genital warts

Country Status (13)

Country	Link
US (1)	US5795911A (en)
EP (1)	EP0842660B1 (en)
JP (1)	JP3213557B2 (en)
KR (1)	KR100312252B1 (en)
CN (1)	CN1086290C (en)
AT (1)	ATE288266T1 (en)
AU (1)	AU716120B2 (en)
CA (1)	CA2221370C (en)
DE (2)	DE69732402T2 (en)
ES (1)	ES2232849T3 (en)
FR (1)	FR12C0077I2 (en)
PT (1)	PT842660E (en)
TW (1)	TW371628B (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6197808B1 (en) *	1996-11-18	2001-03-06	Cancer Instititute (Hospital), Chinese Academy Of Medical Sciences	Methods for treating hyperplasia
US5968973A (en) *	1996-11-18	1999-10-19	Cancer Institute (Hospital), Chinese Academy Of Medical Sciences	Method for treating hyperplasia
AU749958B2 (en)	1997-09-29	2002-07-04	Beijing Huayi Chinese Pharmaceutical Factory	A (fagopyrum cymosum) (trev.) meisn composition, method to prepare and analyze the same and uses thereof
CN1063957C (en)	1997-09-29	2001-04-04	北京华颐中药制药厂	Method for preparing fagopyrum cymosum preparation
EP0938897A1 (en) *	1997-12-26	1999-09-01	Japanese Foundation For Cancer Research	Telomerase inhibitor
US6030622A (en) *	1998-06-23	2000-02-29	Shehadeh; Ahmad Abdallah	Herbal extract composition and method with immune-boosting capability
CA2338328A1 (en) *	1998-07-21	2000-02-03	Thomas Jefferson University	Small molecule inhibitors of bcl-2 proteins
KR100319973B1 (en) *	1998-12-05	2002-04-22	이인수	Cervical epithelial tumor prophylaxis or treatment composition using green tea catechin as an active ingredient
DE60236273D1 (en)	2001-05-03	2010-06-17	Cornell Res Foundation Inc	TREATMENT OF DISEASES CAUSED BY HPV
DE10156794B4 (en) *	2001-11-19	2006-05-18	Medigene Ag	Medicines for the treatment of warts
CA2466720C (en) *	2001-11-19	2010-02-09	Medigene Aktiengesellschaft	Medicament for the treatment of viral skin and tumour diseases
US7108868B2 (en)	2002-03-22	2006-09-19	Unigen Pharmaceuticals, Inc.	Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
US7972632B2 (en)	2003-02-28	2011-07-05	Unigen Pharmaceuticals, Inc.	Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
AU2003228777C1 (en)	2002-04-30	2009-08-13	Unigen, Inc.	Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
US8034387B2 (en) *	2002-04-30	2011-10-11	Unigen, Inc.	Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US8945518B2 (en) *	2002-04-30	2015-02-03	Unigen, Inc.	Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
US7780992B2 (en)	2002-12-08	2010-08-24	Tareq Abduljalil Albahri	Antiviral medicament
CN1798568B (en)	2003-04-04	2011-05-11	尤尼根制药公司	Compositions of dual cyclooxygenase (COX) and lipoxygenase (LOX) inhibitors for mammalian skin care
US7763588B2 (en) *	2003-06-13	2010-07-27	The Salk Institute For Biological Studies	Method for increasing cognitive function and neurogenesis
BRPI0414063A (en) *	2003-09-02	2006-10-24	Unigen Pharmaceuticals Inc	formulation of a mixture of free b-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairment.
EP2292226A3 (en)	2003-10-09	2011-08-10	MediGene AG	The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin
US20050079235A1 (en) *	2003-10-09	2005-04-14	Eggert Stockfleth	Use of a polyphenol for the treatment of actinic keratosis
CN100337690C (en) *	2005-02-07	2007-09-19	上海复旦张江生物医药股份有限公司	Evaluation of efficacy of medicine for moist wart
US20070082073A1 (en) *	2005-05-18	2007-04-12	University Of South Florida	Catechin Adjuvants
US8044098B2 (en) *	2005-08-02	2011-10-25	Shenghua Guangzhou Pharmaceutical Science & Technology Co., Ltd.	Use of hydroxybenzoic acids and their esters and analogues for preventing or treating virus infection
KR100801891B1 (en)	2006-11-02	2008-02-12	한상진	Pharmaceutical composition for preventing or treating genital inflammation using natural materials
EP2179722A1 (en)	2008-10-24	2010-04-28	Heinrich-Pette-Institut für experimentelle Virologie und Immunologie	Topical formation for preventing sexual transmission of viral infection
ES2349966B1 (en) *	2008-10-30	2011-11-18	Ignacio Umbert Millet	TOPICAL FORMULATIONS FOR THE TREATMENT OF VERRUGAS.
US20110218241A1 (en) *	2010-03-06	2011-09-08	Cacao Bio-Technologies, Llc	Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts
WO2012100835A1 (en)	2011-01-28	2012-08-02	Laboratorios Del Dr. Esteve, S.A.	Methods and compositions for the treatment of aids
US10806826B2 (en)	2013-01-09	2020-10-20	Bacterin International, Inc.	Bone graft substitute containing a temporary contrast agent and a method of generating such and a method of use thereof
EP3270914B1 (en)	2015-03-19	2023-06-07	GTO Pharma, LLC.	Compounds and forms of treatment for female sexual disorders
MX367243B (en) *	2016-02-04	2019-08-09	Maria Del Carmen Ramirez Olvera	Composition of plant extracts that increase díderlein's bacilli, used for the treatment of sexually transmitted diseases (std) and the human papillomavirus (hpv), having an aphrodisiac effect.
CN106727275A (en) *	2016-12-15	2017-05-31	珠海聚焦先导生物研究院有限公司	A kind of suppository composition for treating vaginitis
CN107349197A (en) *	2017-07-13	2017-11-17	黄冈师范学院	A kind of application of catechin on the medicine for preparing treatment cutaneous papilloma
IT202200013867A1 (en) *	2022-06-30	2023-12-30	Lo Li Pharma Srl	COMPOSITION FOR THE TREATMENT OF PAPILLOMA VIRUS (HPV) INFECTION
US12111395B2 (en) *	2023-01-30	2024-10-08	Semiconductor Components Industries, Llc	Acoustic sensing of proximate obstacles
WO2025227040A1 (en) *	2024-04-26	2025-10-30	Amplexd Therapeutics, Inc.	Pharmaceutical compositions and methods for treatment of intraepithelial dysplasia and neoplasia

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2128207B1 (en) *	1971-03-11	1974-08-02	Zyma Sa
US5159069A (en) *	1988-12-20	1992-10-27	Yamanouchi Pharmaceutical Co., Ltd.	Sulfated tannins and their salts
JP2727471B2 (en) *	1989-09-14	1998-03-11	三井農林株式会社	Influenza virus infection prevention agent
JPH03141220A (en) *	1989-10-26	1991-06-17	Tsumura & Co	Antiretroviral agent
JP3019996B2 (en) *	1990-03-01	2000-03-15	三井農林株式会社	Ringworm treatment
US5211944A (en) *	1990-10-12	1993-05-18	Shaman Pharmaceuticals, Inc.	Proanthocyanidin polymers having antiviral activity and methods of obtaining same
DE4211238C2 (en) *	1992-04-03	1994-10-27	Edward I Budowskij	Use of 2 ', 5'-oligoadenylates for the treatment of papillomatoses
US5605929A (en) *	1992-05-27	1997-02-25	Arch Development Corp.	Methods and compositions for inhibiting 5α-reductase activity
US5648377A (en) *	1993-12-21	1997-07-15	Indena S.P.A.	Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals
GB2293548A (en) *	1994-09-29	1996-04-03	Joan Louise Hibberd	Treatment of herpes infections
IT1275905B1 (en) *	1995-03-14	1997-10-24	Indena Spa	POLYPHENOLIC FRACTIONS OF TEA, THEIR USE AND FORMULATIONS THAT CONTAIN THEM
US5576013A (en) *	1995-03-21	1996-11-19	Eastern Virginia Medical School	Treating vascular and neoplastic tissues
JPH1036260A (en) *	1996-07-18	1998-02-10	Mitsui Norin Kk	Methods for enhancing the efficacy of anticancer drugs

1996
- 1996-11-18 JP JP32119596A patent/JP3213557B2/en not_active Expired - Lifetime
1997
- 1997-04-10 US US08/835,920 patent/US5795911A/en not_active Expired - Lifetime
- 1997-10-21 TW TW086115494A patent/TW371628B/en not_active IP Right Cessation
- 1997-11-10 AU AU44438/97A patent/AU716120B2/en not_active Expired
- 1997-11-17 CN CN97122670A patent/CN1086290C/en not_active Expired - Lifetime
- 1997-11-17 CA CA002221370A patent/CA2221370C/en not_active Expired - Lifetime
- 1997-11-18 ES ES97120182T patent/ES2232849T3/en not_active Expired - Lifetime
- 1997-11-18 AT AT97120182T patent/ATE288266T1/en active
- 1997-11-18 DE DE69732402T patent/DE69732402T2/en not_active Expired - Lifetime
- 1997-11-18 DE DE200912000072 patent/DE122009000072I2/en active Active
- 1997-11-18 EP EP97120182A patent/EP0842660B1/en not_active Expired - Lifetime
- 1997-11-18 KR KR1019970060940A patent/KR100312252B1/en not_active Expired - Fee Related
- 1997-11-18 PT PT97120182T patent/PT842660E/en unknown
2012
- 2012-12-20 FR FR12C0077C patent/FR12C0077I2/en active Active

Also Published As

Publication number	Publication date
KR100312252B1 (en)	2002-02-19
DE122009000072I1 (en)	2010-03-25
EP0842660A1 (en)	1998-05-20
DE69732402T2 (en)	2006-01-19
PT842660E (en)	2005-05-31
EP0842660B1 (en)	2005-02-02
JP3213557B2 (en)	2001-10-02
TW371628B (en)	1999-10-11
KR19980042555A (en)	1998-08-17
FR12C0077I1 (en)	2013-02-01
JPH10147525A (en)	1998-06-02
CA2221370C (en)	2004-03-02
US5795911A (en)	1998-08-18
CA2221370A1 (en)	1998-05-18
DE69732402D1 (en)	2005-03-10
CN1185947A (en)	1998-07-01
DE122009000072I2 (en)	2011-07-21
AU716120B2 (en)	2000-02-17
AU4443897A (en)	1998-06-04
CN1086290C (en)	2002-06-19
ATE288266T1 (en)	2005-02-15
ES2232849T3 (en)	2005-06-01

Publication	Publication Date	Title
FR12C0077I2 (en)	2013-08-16	Composition for the treatment of genital warts
FR07C0046I2 (en)	2008-05-09	BETA-L-2'-DESOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B
MA25823A1 (en)	2003-07-01	COMPOSITIONS FOR THE TREATMENT OF WATER.
CH1143977H1 (en)	2007-02-15	2-Oxy-benzoxazine-4-ones for the treatment of obesity
DE69728594D1 (en)	2004-05-19	Chromium-free composition for the treatment of metal surfaces
DZ3014A1 (en)	2004-03-27	Medicines for the treatment of hypertension.
DE69519577D1 (en)	2001-01-11	PREDNISOLONMETASULFOBENZOATE COMPOSITION FOR TREATING INFLAMMATORY DISEASE OF THE COLON
EP0975654A4 (en)	2002-04-10	COMPOSITIONS AND METHODS FOR THE TREATMENT OF CYTOMEGALOVIRUS INFECTIONS
EP1305015A4 (en)	2003-05-21	STYRYL BENZYLSULFONES SUBSTITUTED FOR THE TREATMENT OF PROLIFERATIVE DISORDERS
EP0959879A4 (en)	2000-03-29	PHOTODYNAMIC THERAPY FOR THE TREATMENT OF ARTHROSIS
EP0761604A3 (en)	1997-06-25	Water treatment agent
EP1359885A4 (en)	2005-03-16	INHIBITORS OF NOS FOR THE TREATMENT OF WRINKLES
EP1161255A4 (en)	2002-07-17	METHODS AND COMPOSITIONS FOR THE TREATMENT OF DYSERECTION
FR2758465B1 (en)	1999-04-09	COMPOSITION FOR THE TREATMENT OF ASBESTOS
FR2746658B1 (en)	1998-06-19	IMPLANTABLE DRAINAGE VALVE FOR THE TREATMENT OF HYDROCEPHALIA
EP0860867A4 (en)	1999-09-29	SURFACE TREATMENT FOR MICRO-MACHINING
FR2800614B1 (en)	2002-01-04	COMPOSITION FOR THE TREATMENT OF RESPIRATORY INFECTIONS
MA24569A1 (en)	1998-12-31	FARNESYL-TRANSFERASE INHIBITORS IN ASSOCIATION WITH HMG-COA-REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER
DZ1988A1 (en)	2002-07-20	Combination therapy for the treatment of winter.
FR2786096B1 (en)	2002-10-18	COMPOSITION FOR THE PREVENTION AND TOPICAL TREATMENT OF CELLULITE
MA23837A1 (en)	1996-12-31	BENZAMIDES FOR THE TREATMENT OF NEUROLOGICAL DEGENERES
FR2751544B1 (en)	1998-09-04	THERAPEUTIC COMPOSITION FOR THE TREATMENT OF VULGAR WARTS
MA25852A1 (en)	2003-07-01	METHOD FOR THE TREATMENT OF INFLAMMATION.
EP1172113A4 (en)	2004-06-30	REMEDIES FOR THE TREATMENT OF AUTOMATIC NEUROPATHIES
EP0672457A3 (en)	1996-02-07	Process for residue-free treatment of waste.